New Plaque Psoriasis Medication Receives FDA Approval

Roni Shye
Roni Shye, PharmD BCGP BCACP, is a licensed pharmacist in the states of Florida, Ohio, and Pennsylvania.
Posted on

Plaque psoriasis is a skin disorder that causes thick, scaly, red skin which can be painful and itchy. Treatments for plaque psoriasis come in various types of forms including oral, injectable and topical. Your doctor will determine the best course of treatment for you as no single psoriasis treatment works for everyone.

Recently, Ilumya, was approved by the FDA for the treatment of moderate-to-severe plaque psoriasis.  

What is Ilumya indicated for?

Ilumya is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic or phototherapy.

Ilumya will be available as a single-dose prefilled syringe in a strength of 100 mg/ml. Ilumya is to be injected under the skin (subcutaneously) at weeks 0, 4, and every 12 weeks thereafter, and should only be administered by a healthcare provider.

Before starting Ilumya is there anything I should consider?

Yes. Before starting Ilumya make sure to do the following:

What are the most common side effects associated with Ilumya?

The most common side effects associated with Ilumya are as follows:

For more information on Ilumya, read the press release from Sun Pharmaceuticals here.

Put drug prices & coupons in your pocket!
We'll text you a link to download our free Android or iPhone app
Get GoodRx Mobile App

Filed under